Publication Name	World Journal of Hepatology
Manuscript ID	25566
Country	Italy

Received	2016-03-15 10:27
Peer-Review Started	2016-03-16 19:02
To Make the First Decision	2016-05-17 12:21
Return for Revision	2016-05-18 11:30
Revised	2016-05-23 20:24
Second Decision	2016-06-02 08:28
Accepted by Journal Editor-in-Chief	2016-06-02 18:07
Accepted by Company Editor-in-Chief	2016-06-16 11:31
Articles in Press	2016-06-16 11:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-06-28 10:31
Publish the Manuscript Online	2016-07-06 09:19

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Sofosbuvir/velpatasvir: A promising combination
Manuscript Source	Invited Manuscript
All Author List	Aldo Bonaventura and Fabrizio Montecucco
Funding Agency and Grant Number
Corresponding Author	Fabrizio Montecucco, MD, PhD, Assis­tant Professor, First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, 6 viale Benedetto XV, 16132 Genoa, Italy. fabrizio.montecucco@unige.it
Key Words	Hepatitis C virus; Sofosbuvir; Velpatasvir; NS5A inhibitor; NS5B inhibitor
Core Tip	Hepatitis C virus (HCV) spread all over the world. In the last years, new therapies with direct anti-viral agents draw a great revolution thanks to several oral regimens combining different drugs of this class. The present editorial provides a brief overview on the association between two direct antiviral agents, sofo-zsbuvir and velpatasvir, and their implication in the treat-ment of HCV infection.
Publish Date	2016-07-06 09:19
Citation	Bonaventura A, Montecucco F. Sofosbuvir/velpatasvir: A promising combination. World J Hepatol 2016; 8(19): 785-789
URL	http://www.wjgnet.com/1948-5182/full/v8/i19/785.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i19.785

Full Article (PDF)	WJH-8-785.pdf
Full Article (Word)	WJH-8-785.doc
Manuscript File	25566-Review.docx
Answering Reviewers	25566-Answering reviewers.pdf
Audio Core Tip	25566-Audio core tip.wav
Conflict-of-Interest Disclosure Form	25566-Conflict-of-interest statement.pdf
Copyright License Agreement	25566-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	25566-Language certificate.pdf
Peer-review Report	25566-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	25566-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	25566-Scientific misconduct check.pdf
Scientific Editor Work List	25566-Scientific editor work list.pdf